ArticleCanadian journal of physiology and pharmacology2022

Endothelin antagonism reduces hemoglobin A1c in patients with pulmonary hypertension.

Jennifer R Stapel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.